These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8513844)

  • 1. Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slow-release tablet of miconazole.
    Bouckaert S; Lefebvre RA; Colardyn F; Remon JP
    Eur J Clin Pharmacol; 1993; 44(4):331-5. PubMed ID: 8513844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of salivary miconazole concentrations after administration of a bioadhesive slow-release buccal tablet and an oral gel.
    Bouckaert S; Schautteet H; Lefebvre RA; Remon JP; van Clooster R
    Eur J Clin Pharmacol; 1992; 43(2):137-40. PubMed ID: 1425869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro bioadhesion of a buccal, miconazole slow-release tablet.
    Bouckaert S; Remon JP
    J Pharm Pharmacol; 1993 Jun; 45(6):504-7. PubMed ID: 8103096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet.
    Bouckaert S; Lefebvre RA; Remon JP
    Pharm Res; 1993 Jun; 10(6):853-6. PubMed ID: 8321853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects.
    Cardot JM; Chaumont C; Dubray C; Costantini D; Aiache JM
    Br J Clin Pharmacol; 2004 Oct; 58(4):345-51. PubMed ID: 15373926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slow-release tablets containing miconazole nitrate.
    Mohammed FA; Khedr H
    Drug Dev Ind Pharm; 2003 Mar; 29(3):321-37. PubMed ID: 12741613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miconazole mucoadhesive gingival tablet: new drug. Oropharyngeal candidiasis: new form of tablet with no proven advantages.
    Prescrire Int; 2008 Oct; 17(97):190. PubMed ID: 19534042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses.
    Vivien-Castioni N; Gurny R; Baehni P; Kaltsatos V
    Eur J Pharm Biopharm; 2000 Jan; 49(1):27-33. PubMed ID: 10613924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing.
    Nafee NA; Ismail FA; Boraie NA; Mortada LM
    Int J Pharm; 2003 Oct; 264(1-2):1-14. PubMed ID: 12972331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a buccal bioadhesive nystatin tablet on the lifetime of a Provox silicone tracheoesophageal voice prosthesis.
    Ameye D; Honraet K; Loose D; Vermeersch H; Nelis H; Remon JP
    Acta Otolaryngol; 2005 Mar; 125(3):304-6. PubMed ID: 15966702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Buccal Adhesive Tablet with Prolonged Antifungal activity: Optimization and ex vivo Deposition Studies.
    Madgulkar A; Kadam S; Pokharkar V
    Indian J Pharm Sci; 2009 May; 71(3):290-4. PubMed ID: 20490296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release from directly compressible theophylline buccal tablets.
    Boyapally H; Nukala RK; Bhujbal P; Douroumis D
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):227-33. PubMed ID: 20188529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of morphine after administration of a new bioadhesive buccal tablet.
    Beyssac E; Touaref F; Meyer M; Jacob L; Sandouk P; Aiache JM
    Biopharm Drug Dispos; 1998 Sep; 19(6):401-5. PubMed ID: 9737821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole.
    Yong CS; Jung JH; Rhee JD; Kim CK; Choi HG
    Drug Dev Ind Pharm; 2001 May; 27(5):447-55. PubMed ID: 11448052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of salivary fluoride concentrations after administration of a bioadhesive slow-release tablet and a conventional fluoride tablet.
    Bottenberg P; Cleymaet R; de Muynck C; Remon JP; Coomans D; Slop D
    J Pharm Pharmacol; 1992 Aug; 44(8):684-6. PubMed ID: 1359097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets.
    Shanker G; Kumar CK; Gonugunta CS; Kumar BV; Veerareddy PR
    AAPS PharmSciTech; 2009; 10(2):530-9. PubMed ID: 19424804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research studies on in vitro and ex vivo yield of the miconazole nitrate from oral biomucoadhesive tablets.
    Birsan M; Cojocaru I; Scutariu MM; Popovici I
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):225-31. PubMed ID: 24741805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of fluoride in the oral cavity after application of a bioadhesive fluoride-releasing tablet.
    Bottenberg P; Bultmann C; Gräber HG
    J Dent Res; 1998 Jan; 77(1):68-72. PubMed ID: 9437401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray-dried Amioca starch/Carbopol 974P mixtures as buccal bioadhesive carriers.
    Ameye D; Mus D; Foreman P; Remon JP
    Int J Pharm; 2005 Sep; 301(1-2):170-80. PubMed ID: 16019172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use.
    Bottenberg P; Cleymaet R; de Muynck C; Remon JP; Coomans D; Michotte Y; Slop D
    J Pharm Pharmacol; 1991 Jul; 43(7):457-64. PubMed ID: 1682457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.